We are live on ! Find out more
VMD icon

Viemed Healthcare

131 hedge funds and large institutions have $166M invested in Viemed Healthcare in 2025 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 43 increasing their positions, 47 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 9

3% more funds holding

Funds holding: 127131 (+4)

9% less repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 47

1.69% less ownership

Funds ownership: 64.78%63.09% (-1.7%)

6% less capital invested

Capital invested by funds: $177M → $166M (-$10.8M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
131
Holders Change
+4
Holders Change %
+3.15%
% of All Funds
1.72%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
13
Increased
43
Reduced
47
Closed
9
Calls
Puts
$1K
Net Calls
-$1K
Net Calls Change
-$1K

VMD Hedge Fund Activity: Q3 2025 in Review

131 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q3 2025, worth a combined $166M — down 6.1% from $177M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new VMD positions and 9 closed out — a net gain of 4 holders — while 43 added to existing stakes and 47 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $4.33M. The largest seller was Wasatch Advisors, exiting entirely with an estimated $10.7M sold.

  • 131 institutional investors held Viemed Healthcare (VMD) as of Q3 2025, up from 127 in Q2 2025.
  • Funds reported $166M of Viemed Healthcare stock for Q3 2025, down 6.1% quarter-over-quarter.
  • 13 funds opened new Viemed Healthcare positions in Q3 2025 and 9 closed out, a net change of +4 holders.
  • The largest Viemed Healthcare buyer in Q3 2025 was Goldman Sachs, an estimated $4.33M added.
  • The largest Viemed Healthcare seller in Q3 2025 was Wasatch Advisors, an estimated $10.7M sold.

Based on aggregated 13F filings for Q3 2025.